Tag: GA
ODs Should Be Proactive in Identifying Patients at Risk for AMD
A patient’s age-related macular degeneration (AMD) at any stage should rise to a high level of importance for optometrists. Imaging is important to feel...
Having the Difficult Discussion With Patients on Geographic Atrophy
As one of the ODs at Ohio’s Cincinnati Eye Institute, Mary Beth Yackey, OD, often sees patients with progressing ocular diseases. Patients who are...
Iveric Bio Receives U.S. FDA Approval for IZERVAY™ (avacincaptad pegol intravitreal...
– IZERVAY is the only approved GA treatment with a statistically significant reduction in the rate of GA progression at the 12-month primary endpoint across...
Detecting Geographic Atrophy is in Optometry’s Wheelhouse
Optical coherence tomography (OCT) is a great, non-invasive imaging modality that many ODs are using in their practices. However, OCTs are often ordered only...
You’ve Identified a GA Patient. Now What?
Early detection of geographic atrophy (GA) and timely referral may help maintain the quality of vision patients deserve for longer.1
Iveric Bio has developed a...
How Are You Managing Patients With Geographic Atrophy?
Geographic atrophy (GA), an advanced form of dry age-related macular degeneration (AMD), is defined by the presence of sharply demarcated atrophic lesions of the...
Geographic Atrophy By the Numbers
About 1.5 million people in the U.S. are affected by geographic atrophy (GA), according to data presented in factsheet from Iveric Bio: Geographic Dystrophy...
Geographic Atrophy: The Importance of Imaging
Imaging is critical to the detection and monitoring of geographic atrophy (GA). In The Importance of Imaging, SriniVas Sadda, MD, talks with Eric Donnefeld,...
The Impact of GA Disease Progression
In a two-minute video, Carl Danzig, OD, narrates the impact of progressive geographic atrophy (GA) in one of his patients. The video details how,...
